Match!
Gui De Backer
Ghent University
CardiologyPhysical therapyPopulationDiabetes mellitusMedicine
859Publications
82H-index
57.8kCitations
What is this?
Publications 838
Newest
#1Delphine De Smedt (UGent: Ghent University)H-Index: 18
#2Kornelia Kotseva (Imperial College Healthcare)H-Index: 27
Last. Dirk De Bacquer (UGent: Ghent University)H-Index: 72
view all 6 authors...
Objective Coronary patients often suffer from an impaired health, hence the aim of this study is to assess how coronary patients score on the different EQ-5D dimensions.
Source
#1Giulia Ferrannini (UNITO: University of Turin)H-Index: 1
#2Dirk De Bacquer (UGent: Ghent University)H-Index: 72
Last. Lars Rydén (European Society of Cardiology)H-Index: 91
view all 7 authors...
OBJECTIVE Dysglycemia, in this survey defined as impaired glucose tolerance (IGT) or type 2 diabetes, is common in patients with coronary artery disease (CAD) and associated with an unfavorable prognosis. This European survey investigated dysglycemia screening and risk factor management of patients with CAD in relation to standards of European guidelines for cardiovascular subjects. RESEARCH DESIGN AND METHODS The European Society of Cardiology’s European Observational Research Programme (ESC EO...
Source
Source
#1Maciej HaberkaH-Index: 12
#2Piotr JankowskiH-Index: 19
Last. Karol KaminskiH-Index: 16
view all 18 authors...
Source
#1Delphine De Smedt (UGent: Ghent University)H-Index: 18
#2T De Backer (UGent: Ghent University)H-Index: 21
Last. Dirk De Bacquer (UGent: Ghent University)H-Index: 72
view all 7 authors...
Abstract Background As advised by the European guidelines on cardiovascular prevention, medication intake is a major component of secondary prevention. The aim of this study is to provide an in-depth overview of the medication intake in stable European coronary heart disease (CHD) patients. Methods Analyses are based on the EUROASPIRE IV survey, including CHD patients (18 to 80 years) who were hospitalized for a coronary event. These patients were interviewed and examined 6 months to 3 years aft...
1 CitationsSource
#1Olivier S. Descamps (Cliniques Universitaires Saint-Luc)H-Index: 25
#1O. S. Descamps (Cliniques Universitaires Saint-Luc)H-Index: 5
Last. Gui De Backer (UGent: Ghent University)H-Index: 82
view all 10 authors...
ABSTRACTIt has been well established that low-density lipoproteins (LDL) and other apolipoprotein B-containing lipoproteins are causally related to atherosclerotic cardiovascular disease (ASCVD) an...
Source
#1François MachH-Index: 58
#2Colin BaigentH-Index: 66
Last. Riyaz S. PatelH-Index: 31
view all 121 authors...
246 CitationsSource
#1François Mach (Geneva College)H-Index: 58
#2Colin Baigent (University of Oxford)H-Index: 66
Last. Rhian M. TouyzH-Index: 97
view all 96 authors...
Source
#1Kornelia Kotseva (Imperial College London)H-Index: 27
#2Gui De Backer (UGent: Ghent University)H-Index: 82
Last. David R. WoodH-Index: 111
view all 10 authors...
Source
#1Dirk De Bacquer (UGent: Ghent University)H-Index: 72
#2Delphine De Smedt (UGent: Ghent University)H-Index: 18
Last. Guy De Backer (UGent: Ghent University)H-Index: 25
view all 9 authors...
AimsRecent European guidelines recommend in patients with atherosclerotic cardiovascular disease to achieve a reduction of low-density lipoprotein-cholesterol of at least 50% if the baseline low-de...
Source
12345678910